- AstraZeneca reported Q3 net profit of $3.12 billion, up from $2.535 billion in the same period last year, on strong cancer-drug sales.
- AstraZeneca stock jumped after the Q3 earnings beat on strong oncology sales.
- CFO Aradhana Sarin said AstraZeneca uses AI in almost every aspect of its work and discussed earnings, the drug pipeline and dealmaking on Bloomberg Surveillance.
Quotes
“the drug company uses AI in almost every aspect of the work they do”